iCeutica's GMP scales-up for nano prods

Philadelphia, USA-based iCeutica says the first Good Manufacturing Practices-compliant clinical supplies have been manufactured for its partner, Iroko Pharmaceuticals, utilizing the former's proprietary nano-sizing technology. The completion of the manufacturing campaign represents an important technical and commercial validation of the iCeutica platform, the firm says.

The firms are collaborating on the application of iCeutica's nano-sizing platform to reformulate certain proprietary Iroko products. Iroko is guiding the progression of these reformulated products through the regulatory process, clinical trials and ultimate commercial launch.

"iCeutica's nano-sizing platform is broadly applicable to a wide range of poorly soluble drug compounds and provides a novel and exciting approach to formulation development and drug product manufacturing. We look forward to working with our partners and on our internal pipeline in maximizing the potential of this important new technology," said chief executive Matt Callahan.